Contact Lens Recall Emphasized By FDA

- Third Age

11/02/2011 - A contact lens recall is being issued for 600,000 Avaira Toric contact lenses for the second time in two months, and the FDA is causing the case to be more apparent to the public.

CooperVision is one of the U.S.’s largest eye care companies, and they made their first recall on August 19th. The lenses being recalled caused symptoms such as red eye, blurry vision and pain, including several wearers rushing to the emergency room.

According to the FDA, the company needed to put more effort into making customers aware of the recall. The defective products contained residue due to a manufacturing problem. In an e-mail statement, FDA spokesperson Morgan Liscinsky said the agency is looking over CooperVision’s most recent announcement to determine whether it adequately addresses the FDA’s concerns.

"Failing resolution of those concerns, the FDA may issue a separate public communication," said Liscinsky’s statement, as quoted by CBS.

CopperVision claimed it has cooperated fully with the FDA and is keeping a close eye on the situation. As of now, the company is unaware of any permanent damage caused by the lenses.

According to the FDA, over 8 million lenses are affected but only 600,000 made it onto the U.S. market.

Defective Contact Lens Lawsuit

If you or a loved one have suffered or been injured by defective CooperVision Avaira Contact Lenses you may be entitled to compensation. Contact the Avaira contact lens recall attorneys of Ennis & Ennis today for a free confidential case evaluation. Our on staff nurse and lawyers are standing by to answer any questions you may have regarding the CooperVision Avaira recall, a possible Avaira contacts class action lawsuit, or any other type of contact lens litigation.